home / stock / vnda / vnda articles

VNDA Articles, Vanda Pharmaceuticals Inc. - From 04/03/24

Stock Information
Company Name: Vanda Pharmaceuticals Inc.
Stock Symbol: VNDA
Market: NASDAQ
Website: vandapharma.com
Menu
VNDA VNDA Quote VNDA Short VNDA News VNDA Articles VNDA Message Board
Get VNDA Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Is Vanda Pharmaceuticals Stock Trading Higher Today? | Benzinga

Tuesday, the FDA approved Vanda Pharmaceuticals Inc’s (NASDAQ:VNDA) Fanapt (iloperidone) tablets for the acute treatment of manic o...
Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Cal-Maine Foods, Inc. (NASDAQ: CALM) rose sharply in today’s pre-market trading after the company reported upbeat results for its ...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA | Benzinga

NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceutical Inc. ("Vanda"?...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. – VNDA | Benzinga

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceuticals Inc. ("Vanda"...
Vanda Pharmaceuticals Acquires Rights To Multiple Sclerosis Drug From Johnson & Johnson's Company | Benzinga

Vanda Pharmaceuticals Inc (NASDAQ: VNDA) has acquired U.S. and Canadian rights to Ponvory (ponesimod) from Actelion Pharmaceuticals Ltd, ...

Vanda Pharmaceuticals Acquires U.S. and Canadian Rights to PONVORY® (ponesimod), a Selective S1P1R Modulator Approved for Patients with Relapsing Multiple Sclerosis | Benzinga

WASHINGTON, Dec. 7, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that it has acquired U.S. and Canadian ri...

Previous 10 Next 10